Publicaciones en colaboración con investigadores/as de Centro Nacional de Investigaciones Oncológicas (13)

2023

  1. Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma

    Nature Medicine, Vol. 29, Núm. 3, pp. 632-645

2020

  1. Frequent mutations in the amino-terminal domain of BCL7A impair its tumor suppressor role in DLBCL

    Leukemia, Vol. 34, Núm. 10, pp. 2722-2735

2017

  1. Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies

    Nature Communications, Vol. 8

2012

  1. Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia

    Leukemia, Vol. 26, Núm. 7, pp. 1517-1526

2011

  1. A cyclin-D1 interaction with BAX underlies its oncogenic role and potential as a therapeutic target in mantle cell lymphoma

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 108, Núm. 30, pp. 12461-12466

  2. Molecular characterization of the region 7q22.1 in splenic marginal zone lymphomas

    PLoS ONE, Vol. 6, Núm. 9

  3. PIM2 inhibition as a rational therapeutic approach in B-cell lymphoma

    Blood, Vol. 118, Núm. 20, pp. 5517-5527

2007

  1. Generation of a new monoclonal antibody against MALT1 by genetic immunization

    Hybridoma, Vol. 26, Núm. 2, pp. 86-91

  2. Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas

    Blood, Vol. 109, Núm. 1, pp. 271-280

2003

  1. Abnormalities on 1q and 7q are associated with poor outcome in sporadic Burkitt's lymphoma. A cytogenetic and comparative genomic hybridization study

    Leukemia, Vol. 17, Núm. 10, pp. 2016-2024

  2. Genomic abnormalities acquired in the blastic transformation of splenic marginal zone B-cell lymphoma

    Leukemia and Lymphoma, Vol. 44, Núm. 3, pp. 459-464

  3. Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations

    Blood, Vol. 101, Núm. 10, pp. 4042-4046

  4. The Molecular Signature of Mantle Cell Lymphoma Reveals Multiple Signals Favoring Cell Survival

    Cancer Research, Vol. 63, Núm. 23, pp. 8226-8232